Telehealth companies are increasingly using influencers to promote compounded weight-loss medications, with compensation rising dramatically, from $15,000 for a short ad to $20,000 for social media placements.
Individuals like Susan Graham and Jasmines Vanity are showcasing their weight-loss journeys on platforms such as TikTok, encouraging their followers to try semaglutide or tirzepatide through linked promotions.
The rise in popularity of compounded GLP-1 drugs is partly due to shortages of FDA-approved versions, creating a lucrative market for telehealth companies that connect influencers with consumers.
Collection
[
|
...
]